Life Scientist > Health & Medical

Lorne 2009 profile: Kenneth Kinzler

17 February, 2009 by Kate McDonald

Working with Bert Vogelstein, Ken Kinzler has managed to explore new terrain in our understanding of cancer, particular the genetic basis of colon cancer.


Breast cancer susceptibility in Chinese women

16 February, 2009 by Kate McDonald

Significant breast cancer risk SNP identified in Chinese population


Metabolomics marks out prostate cancer

13 February, 2009 by Kate McDonald

Sarcosine a potential biomarker for prostate cancer progression


IGF-1 and Rett syndrome

11 February, 2009 by Kate McDonald

IGF-1 ameliorates symptoms in mouse model of Rett syndrome


Potent effects for BDNF in Alzheimer’s models

09 February, 2009 by Kate McDonald

US research finds neuroprotective effect for BDNF in animal models of Alzheimer’s


Bench to bedside for cancer

06 February, 2009 by Staff Writers

New cancer research facility launched at WEHI


Brainy boost for medical research

29 January, 2009 by Staff Writers

$4 million Australia Fellowships for biomedical research announced


SNP link to several cancers

20 January, 2009 by Kate McDonald

Research finds common sequence variants in many cancer types


Single gene mutation affects 60 million

19 January, 2009 by Kate McDonald

A deletion in a single gene increases risk of cardiomyopathies in South Asian populations


Robotnikinin takes on Sonic hedgehog

19 January, 2009 by Kate McDonald

Sonic the hedgehog's nemesis strikes again, biologically speaking


Solving the case of the fainting astronaut

16 January, 2009 by Kate McDonald

A fascinating International Space Station-based research project about deconditioning of the autonomic nervous system could help future space travellers and other earthlings.


Alzheimer’s and the X factor

12 January, 2009 by Kate McDonald

Study finds sex-specific risk SNP for late-onset Alzheimer’s


HDIs and oncology’s great hope

10 December, 2008 by Graeme O'Neill

Histone deacetylase inhibitors (HDIs) have emerged as oncology’s Great Hope – rarely has a new class of drugs showed promise against such a broad range of cancers, including leukaemias, lymphomas and solid tumours.


Editing cancer with the immune system

09 December, 2008 by Fiona Wylie

Mark Smyth is investigating a long-suspected but previously unproven role of the immune system – keeping cancer development in a holding pattern such that it neither grows nor gets ‘cured’.


Starpharma adds to STI inhibition

04 December, 2008 by Kate McDonald

Microbicide inhibits HPV 16 and 18 in vivo


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd